Workflow
LabTech(688056)
icon
Search documents
莱伯泰科(688056) - 2020 Q3 - 季度财报
2020-10-25 16:00
Financial Performance - Revenue for the first nine months decreased by 10.76% to CNY 225,128,398.73 compared to the same period last year[6]. - Net profit attributable to shareholders decreased by 7.90% to CNY 36,269,703.32 compared to the same period last year[6]. - Basic and diluted earnings per share decreased by 11.39% to CNY 0.70[7]. - The total comprehensive income for the first three quarters of 2020 was ¥36,286,894.32, down from ¥39,389,419.68 in the same period of 2019, a decrease of about 7.1%[31]. - The net profit for the first three quarters of 2020 was ¥22,135,954.97, compared to ¥18,432,347.41 in the same period of 2019, reflecting an increase of approximately 20.0%[35]. - The net profit for Q3 2020 was ¥16,772,315.61, compared to ¥13,507,594.53 in Q3 2019, reflecting an increase of about 24.4%[31]. - The net profit attributable to the parent company for Q3 2020 was ¥16,702,707.60, compared to ¥13,512,711.74 in Q3 2019, representing an increase of approximately 23.0%[32]. Assets and Liabilities - Total assets increased by 79.88% to CNY 808,801,045.94 compared to the end of the previous year[6]. - The company's total assets amounted to CNY 808,801,045.94, a significant increase from CNY 449,621,497.79 as of December 31, 2019, reflecting a growth of approximately 80%[24]. - The company's current assets reached CNY 713,294,448.07, compared to CNY 351,070,652.83 at the end of 2019, indicating a growth of about 103%[23]. - The company's total liabilities decreased to CNY 91,261,047.00 from CNY 122,109,807.86, a reduction of about 25%[24]. - Total liabilities decreased to ¥30,672,844.31 from ¥39,070,622.51 year-over-year, a decline of approximately 21.5%[28]. - Current liabilities reached CNY 119,595,723.56, including accounts payable of CNY 32,253,229.77 and short-term borrowings of CNY 7,684,566.70[44]. Cash Flow - Operating cash flow increased by 348.25% to CNY 42,830,583.18 for the period from January to September[6]. - The net cash flow from operating activities for the first three quarters of 2020 was CNY 42,830,583.18, significantly up from CNY 9,554,960.65 in the same period of 2019, indicating a growth of approximately 348.5%[38]. - Cash inflow from operating activities totaled CNY 272,368,049.30 for the first three quarters of 2020, slightly down from CNY 278,803,624.52 in 2019, a decrease of about 2.5%[37]. - The net cash flow from financing activities was CNY 339,388,632.12 in the first three quarters of 2020, compared to a net outflow of CNY 30,000,000.00 in the same period of 2019, marking a turnaround of CNY 369,388,632.12[38]. - The cash and cash equivalents at the end of the third quarter of 2020 amounted to CNY 566,412,908.85, a significant increase from CNY 151,426,736.46 at the end of the same quarter in 2019, reflecting a growth of approximately 273.5%[38]. Shareholder Information - The total number of shareholders reached 7,857 by the end of the reporting period[11]. - The largest shareholder, Beijing Laibotai Technology Management Consulting Co., Ltd., holds 36.09% of the shares[11]. - The equity attributable to shareholders rose to CNY 716,743,485.89, up from CNY 326,732,367.90, marking an increase of approximately 119%[25]. Research and Development - R&D expenditure as a percentage of revenue increased by 2.27 percentage points to 8.42%[7]. - Research and development expenses for Q3 2020 were ¥6,503,151.36, slightly up from ¥6,390,795.68 in Q3 2019, indicating a focus on innovation[31]. - Research and development expenses for Q3 2020 were ¥5,010,939.35, compared to ¥3,861,092.85 in Q3 2019, representing an increase of approximately 29.5%[34]. Other Financial Metrics - The company reported a net loss from non-operating activities of CNY 2,071,749.77[9]. - The company recognized a government subsidy income of RMB 485,390.03, a 986.6% increase compared to RMB 44,669.93 in the previous year, attributed to COVID-19 relief measures[18]. - The company incurred an estimated liability of RMB 2,000,000.00 for patent infringement litigation, a new expense not present in the previous year[18]. - The company reported a 63.5% reduction in financial expenses, amounting to RMB -504,569.09, primarily due to fluctuations in exchange rates[18].